Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00623688 · ClinicalTrials.gov registry record · NA
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
A NA study, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00623688 is a NA study that has completed, run by Akron Children's Hospital. The registered enrollment target is 11 participants.
The verdict
NCT00623688, a NA study, has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will be conducted as a randomized, double blinded, controlled trial. The control group will receive albuterol delivered by a nebulizer along with placebo treatments delivered by a metered dose inhaler (MDI) with a spacer +/- mask. The experimental group will receive albuterol delivered by MDI with spacer +/- mask along with placebo treatments given by a nebulizer. Parents, participants, study personnel, nursing staff, and respiratory therapists will not know the treatment assignments of participants. The primary outcome will be changes over time in an asthma severity score, the Clinical Asthma Score (CAS) (Parkin et al. 1996). The secondary outcomes will be total number of albuterol treatments received in the hospital, time it take to give treatments, time till subjects' albuterol treatments are given at four hour intervals, and the costs of the two types of treatments. The study hypothesis is that albuterol delivered by metered dose inhaler with spacer is non-inferior to albuterol delivered by nebulizer in the treatment of children hospitalized with moderate to severe asthma exacerbations.
Interventions
- DEVICE Metered Dose Inhaler & Optichamber Advantage Valve Holding Chamber (VHC)
- DEVICE Airlife Sidestream High Efficiency Nebulizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00623688
The ClinicalTrials.gov registry entry for NCT00623688 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metered Dose Inhaler & Optichamber Advantage Valve Holding Chamber (VHC) is the first listed.
NCT00623688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00623688 about?
NCT00623688 is a clinical study titled "Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital". This study will be conducted as a randomized, double blinded, controlled trial. The control group will receive albuterol delivered by a nebulizer along with placebo treatments delivered by a metered dose inhaler (MDI) with a spacer +/- mask. The experimental group will receive albuterol delivered by...
What is the current status of trial NCT00623688?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-02. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00623688?
The interventions under investigation include: Metered Dose Inhaler & Optichamber Advantage Valve Holding Chamber (VHC) (DEVICE), Airlife Sidestream High Efficiency Nebulizer (DEVICE).
Who is sponsoring clinical trial NCT00623688?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.